ResearchAndMarkets projects the market will grow from $3.47 billion in 2025 at a 5.93% CAGR, driven by rising hepatitis infections, broader screening, point-of-care adoption and diagnostic innovation.
ResearchAndMarkets said the global hepatitis testing market is projected to increase to USD 5.78 billion by 2034 from USD 3.47 billion in 2025, representing a 5.93% compound annual growth rate. The report attributes growth to rising hepatitis infections, chronic liver disease, broader screening efforts, greater use of point-of-care testing and continued product innovation in molecular assays, rapid diagnostic kits and automated platforms. It identifies North America as a key market, says reagents and kits should remain the leading product segment by 2025, and cites AI-driven tools, digital health and telemedicine as opportunities, while noting assay limitations and strict regulatory approval processes as constraints.